Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 4161-4163, September 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, S. B.
Right arrow Articles by Harris, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, S. B.
Right arrow Articles by Harris, A. L.

Relationship of Endothelial Cell Proliferation to Tumor Vascularity in Human Breast Cancer

Stephen B. Fox, Kevin C. Gatter, Roy Bicknell, James J. Going, Peter Stanton, Tim G. Cooke and Adrian L. Harris

Nuffield Department of Pathology [S. B. F., K. C. G.] and Imperial Cancer Research Fund, Institute of Molecular Medicine [R. B., A. L. H.], University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, and Department of Surgery, University of Glasgow, Royal Infirmary, Queen Elizabeth Building, Glasgow G31 2ER [P. S., T. G. C.], and Department of Pathology, University of Glasgow, Royal Infirmary, Castle Street, Glasgow G4 0SF [J. J. G.], United Kingdom

Current studies of tumor angiogenesis rely on the concept that endothelium proliferates 30–40 times faster in tumors than in normal tissues. This evidence is based on histological autoradiographic data largely from animal studies. To assess endothelial cell proliferation in human cancer we used the more sensitive and specific technique of immunohistochemistry. We measured the frequency and distribution of endothelial cell proliferation and examined their relationship to tumor cell proliferation. For the first time, we also correlated endothelial and tumor cell proliferation with tumor vascularity. Twenty breast carcinomas from patients exposed to bromodeoxyuridine 3–8 h prior to surgery were double immunostained using antibodies to CD31 (as a marker of endothelium) and bromodeoxy-uridine (as a marker of proliferation). The labeling index (LI) for both tumor and endothelial cells was determined and tumor vascularity was assessed by counting the number of CD31 positive vessels. Endothelial cell proliferation was predominantly at the tumor periphery while tumor cell proliferation occurred throughout the lesion. The mean LIs for endothelium and tumor were 2.2% (range, 0.8–5.3) and 7.3% (range, 1.3–17.1), respectively. There was no correlation between tumor and endothelial cell LI (P = 0.414) or between the tumor LI or endothelial cell LI and tumor vascularity (P = 0.08 and P = 0.39, respectively). These findings suggest that previous studies in animal tumors have significantly overestimated endothelial cell proliferation and that its importance in tumor angiogenesis may be related more to continual remodeling and migration of vessels than to proliferation alone.

Received 5/21/93. Accepted 8/ 2/93.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Cui, L. M. Lee, X. Heng, W. Zhong, P. W. Sternberg, D. Psaltis, and C. Yang
Lensless high-resolution on-chip optofluidic microscopes for Caenorhabditis elegans and cell imaging
PNAS, August 5, 2008; 105(31): 10670 - 10675.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Riesenberg, C. Weiler, O. Spring, M. Eder, A. Buchner, T. Popp, M. Castro, R. Kammerer, O. Takikawa, R. A. Hatz, et al.
Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma
Clin. Cancer Res., December 1, 2007; 13(23): 6993 - 7002.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Hamada, M. K. Kim, A. Iwakura, M. Ii, T. Thorne, G. Qin, J. Asai, Y. Tsutsumi, H. Sekiguchi, M. Silver, et al.
Estrogen Receptors {alpha} and {beta} Mediate Contribution of Bone Marrow-Derived Endothelial Progenitor Cells to Functional Recovery After Myocardial Infarction
Circulation, November 21, 2006; 114(21): 2261 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. E. Thorpe
Vascular Targeting Agents as Cancer Therapeutics
Clin. Cancer Res., January 15, 2004; 10(2): 415 - 427.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H G Augustin
Translating angiogenesis research into the clinic: the challenges ahead
Br. J. Radiol., December 1, 2003; 76(suppl_1): S3 - S10.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
I. Franck Lissbrant, E. Lissbrant, A. Persson, J.-E. Damber, and A. Bergh
Endothelial Cell Proliferation in Male Reproductive Organs of Adult Rat Is High and Regulated by Testicular Factors
Biol Reprod, April 1, 2003; 68(4): 1107 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Nakamura, H. Yasuoka, M. Tsujimoto, Q. Yang, S. Imabun, M. Nakahara, K. Nakao, M. Nakamura, I. Mori, and K. Kakudo
Prognostic Significance of Vascular Endothelial Growth Factor D in Breast Carcinoma with Long-Term Follow-Up
Clin. Cancer Res., February 1, 2003; 9(2): 716 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J L Xu, R Lai, T Kinoshita, N Nakashima, and T Nagasaka
Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade
J. Clin. Pathol., July 1, 2002; 55(7): 530 - 534.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Giatromanolaki, E. Sivridis, G. Minopoulos, A. Polychronidis, C. Manolas, C. Simopoulos, and M. I. Koukourakis
Differential Assessment of Vascular Survival Ability and Tumor Angiogenic Activity in Colorectal Cancer
Clin. Cancer Res., May 1, 2002; 8(5): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Franco, I. Segura, H. H. Riese, and M. A. Blasco
Decreased B16F10 Melanoma Growth and Impaired Vascularization in Telomerase-deficient Mice with Critically Short Telomeres
Cancer Res., January 1, 2002; 62(2): 552 - 559.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. D. Miller, C. J. Sweeney, and G. W. Sledge Jr
Redefining the Target: Chemotherapeutics as Antiangiogenics
J. Clin. Oncol., February 15, 2001; 19(4): 1195 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. W. Losordo and J. M. Isner
Estrogen and Angiogenesis : A Review
Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 6 - 12.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. J. Andrews, A. Ribas, L. H. Butterfield, C. M. Vollmer, F. C. Eilber, V. B. Dissette, S. D. Nelson, P. Shintaku, S. Mekhoubad, T. Nakayama, et al.
Adenovirus-Interleukin-12-mediated Tumor Regression in a Murine Hepatocellular Carcinoma Model Is Not Dependent on CD1-restricted Natural Killer T Cells
Cancer Res., November 1, 2000; 60(22): 6457 - 6464.
[Abstract] [Full Text]


Home page
Vet PatholHome page
B. Restucci, G. De Vico, and P. Maiolino
Evaluation of Angiogenesis in Canine Mammary Tumors by Quantitative Platelet Endothelial Cell Adhesion Molecule Immunohistochemistry
Vet. Pathol., July 1, 2000; 37(4): 297 - 301.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. I. Koukourakis, A. Giatromanolaki, P. E. Thorpe, R. A. Brekken, E. Sivridis, S. Kakolyris, V. Georgoulias, K. C. Gatter, and A. L. Harris
Vascular Endothelial Growth Factor/KDR Activated Microvessel Density versus CD31 Standard Microvessel Density in Non-Small Cell Lung Cancer
Cancer Res., June 1, 2000; 60(11): 3088 - 3095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K. H. Plate, and H. G. Augustin
Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies
Cancer Res., March 1, 2000; 60(5): 1388 - 1393.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
S. W. McLeskey, C. A. Tobias, P. R. Vezza, A. C. Filie, F. G. Kern, and J. Hanfelt
Tumor Growth of FGF or VEGF Transfected MCF-7 Breast Carcinoma Cells Correlates with Density of Specific Microvessels Independent of the Transfected Angiogenic Factor
Am. J. Pathol., December 1, 1998; 153(6): 1993 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Montrucchio, A. Sapino, B. Bussolati, G. Ghisolfi, S. Rizea-Savu, L. Silvestro, E. Lupia, and G. Camussi
Potential Angiogenic Role of Platelet-Activating Factor in Human Breast Cancer
Am. J. Pathol., November 1, 1998; 153(5): 1589 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. E. Benjamin and E. Keshet
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
PNAS, August 5, 1997; 94(16): 8761 - 8766.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.